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CancerHuman cytomegalovirus utilizes cellular signal transduction pathways to activate viral or cellular transcription
factors involved in the control of viral gene expression and DNA replication. In the present study, we
demonstrate that Harvey-ras-transformed cells show increased permissiveness to human cytomegalovirus
when compared to their parental non-transformed cells. Both the progeny viral yield and the protein levelswere
elevated in the human cytomegalovirus-infected Harvey-ras-transformed cells requiring active viral gene
replication, as shown by the infection with UV-inactivated human cytomegalovirus. Inhibition of Ras or of key
molecules of the Ras pathway, effectively suppressed viral infection in the Harvey-ras-transformed cells. On a
cellular level, the human cytomegalovirus-infected Harvey-ras-transformed cells formed larger cellular foci,
whichwere signiﬁcantly higher in number, compared to the uninfected cells and preferentially recruited human
cytomegalovirus virions, thereby incriminating human cytomegalovirus infection for the increased transfor-
mation of these cells. Furthermore, proliferation assays revealed a higher rate for the human cytomegalovirus-
infected Harvey-ras-transformed cells compared to mock-infected cells, whereas human cytomegalovirus
infection had no considerable effect on the proliferation of the non-transformed cells. Higher susceptibility to
apoptosis was also detected in the human cytomegalovirus-infected ras-transformed cells, which in
combination with the higher progeny virus reveals a mode by which human cytomegalovirus achieves efﬁcient
spread of infection in the cells expressing the oncogenic Harvey-ras (12 V) gene. Collectively, our data suggest
that human cytomegalovirus employs the host-cell Ras signaling pathway to ensue viral expression and
ultimately successful propagation. Transformed cells with an activated Ras signaling pathway are therefore
particularly susceptible to human cytomegalovirus infection.edium; E, Early; EBV, Epstein-
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Human cytomegalovirus (HCMV, HHV-5) is a member of the β-
herpesvidae family of viruses which can cause life-long persistent
infections in the host [1,2]. The HCMV prevalence in the humanpopulation ranges between 50% and 85% and can be explained by its
ability to remain latent for extended periods of time. Reactivation of
the virus can be initiated by inﬂammatory or stress-related signals in
the host organism, resulting in severe and occasionally fatal disease in
immunocompromised individuals. Organ transplant recipients, preg-
nant women and AIDS patients are among the high-risk group due to
their weakened immune system [3,4]. The reactivation of HCMV in
healthy carriers is generally asymptomatic and without any conse-
quences to the host, since these events are well controlled by the host
cell-mediated immunity [5]. Human cytomegalovirus genomes are
transcribed in a temporally deﬁned fashion, and viral genes are
classiﬁed with respect to their temporal expression, into Immediate
Early, Early and Late.
The possible implications ofHCMV infection to the host-cell oncogenic
process have been investigated thoroughly, focusing on the presence of
the virus inmalignant tissues [6–8]. There are increasing data that suggest
the presence of HCMV in several malignant tumors such as colon cancer
[9], EBV-negativeHodgkin's lymphoma [10], prostatic carcinoma [11] and
malignant glioblastoma [12,13]. In addition, HCMV is able to transform
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these cells [14,15]. However, the expression of HCMV antigens decreased
with increasing passage of the transformed cell lines, suggesting that the
transformations occur in a “one-step” process and cease to affect the host
cell therein[16,17]. It was then proposed that HCMV regulates the
oncogenic process by indirect transformation events, termed as “onco-
modulatory events”, and does not affect the tumor cell directly like the
Gamma-herpesviruses Epstein–Barr and Kaposi Sarcoma-associated
herpesvirus [18].
In normal human ﬁbroblasts, HCMV infection activates cellular
proto-oncogenes and kinases involved in cell division and cell survival
pathways, including c-myc, c-fos, c-jun, MAPK, ERK1/2 and PI3-kinase
[19–23]. As regards the MAP kinase pathway, ERK kinases are
activated by HCMV infection through the activation of MAP kinase
kinases and inhibition of phosphatases [24]. A consequence of the
MAP kinase activation by HCMV is the activation of transcription of
viral genes, increasing the expression of viral gene products [25]. In
particular, ERK kinases contribute to the activation of viral genes by
cellular transcription factors, acting through the viral UL4 promoter at
upstream and basal transcription elements. Although the implication
of the downstream of Ras effector molecules, MEK and ERK, is well
documented, the role of the ras gene, as the ﬁrst step of the signaling
cascade, has not been explored. The expression of oncogenic ras in
human teratocarcinoma cells which induces differentiation, results in
the conversion of the cells from a non-permissive to a permissive state
for HCMV infection [26]. In addition, three different cell lines
transformed by HCMV have been shown to harbor an activating
mutation in both alleles in H-ras[27]. However, in both cases, it is
unclear whether the mutations in H-ras were a direct result of the
mutagenic activity of HCMV gene products. It is widely known that
mutations in the ras family genes are found in approximately 30% of
all human tumors, placing these genes in the forefront of cancer
research [28–30]. Considering the capability of HCMV to activate
members of the MAPK kinase pathway in combination with the
increasing evidence for the implication of the virus in several
oncogenic procedures, we sought to investigate the role of the
oncogenic H-ras (12 V) in the context of HCMV infection. We
demonstrate increased permissiveness and viral gene expression in
constitutively activated H-ras cells compared to their parental non-
transformed cells while the inhibition of Ras alone or keymolecules of
the Ras pathway, effectively suppressed viral infection. HCMV
infection induces a higher proliferation rate of the H-ras-transformed
cells and the formation of cellular foci as well as a preferential
localization of the virions onto them. Taken together, these data
suggest that HCMV exploits the Ras signaling pathway in a way that
alters physiological cell proliferation and differentiation.
2. Materials and methods
2.1. Cells
Thepreneoplastic 208F Fischer ratﬁbroblasts [31], amorphologically
ﬂat subclone of NIH3T3 Swiss Embryo ﬁbroblasts and FE-8, which is a
tumorigenic cell clone derived from the 208F cells by co-transfection of
the human EJ-RAS gene and the pSV2neo selection marker [32] were
used in this study. FE-8 cells were cultured in the presence of G418
(400 μg/ml) as a selection marker) (Geneticin; GIBCO). Inducible Ras
cells (IR-4) containing the inducible H-ras (12 V) were generated by
stable transfection of 208F cells with the plasmids pSVlacOras and
pH_lacINLSneo [33]. For the H-ras expression, 20 mM isopropyl-
1thio-β-D galactoside (IPTG) was added to the medium and the IR-4
cells were incubated for 72 h. Human glioblastoma–astrocytoma
epithelial-like U373MG cells were also used in this study to test our
hypothesis in a human cell line [34–36].
The 208F, FE-8 and IR-4 cell lines (kindly provided by R. Schäfer,
Charite, Universitaetsmedizin, Berlin) as well as U373MG cells werecultured in Dulbecco's modiﬁed Eagle's medium (DMEM; Biosera)
supplemented with 10% Fetal Bovine Serum (FBS; Biosera), Penicillin
(100 units/ml and Streptomycin (100 μg/ml) unless otherwise stated.
Human Foreskin Fibroblasts (HFF) were used for the propagation and
titration of HCMV stocks. Cells were incubated at a 37 °C and a 5% CO2
humidiﬁed atmosphere.
2.2. Virus
The AD169 strain of HCMV was used in this study. HCMV stocks
were centrifuged, ultraﬁltrated and titrated as previously described
[37]. Infections of 208F and FE-8 cells were performed at multiplicity
of infection (MOI) of 1 plaque-forming unit (pfu) per cell, i.e. MOI=1
or MOI=0.1 while U373MG cells were infected with HCMV at
MOI=3. The UV-inactivated virus was produced after UV irradiation
(254-nmwavelength) of the active virus stock for 30 min at a distance
of 20 cm [38]. Viral stocks were grown in Human Foreskin Fibroblasts
(HFF) cells and titrated by plaque assays as previously described [39].
Infections in the absence of serum were carried out as previously
described [23]. Brieﬂy, the virus was ﬁrst pelleted at 13,000 rpm for
2 h at 4 °C. The pellet was then gently washed and resuspended in
serum-free medium and pelleted as described above for 1 h. Finally,
the virus pellet was resuspended in serum-free medium, dimethyl
sulfoxide (DMSO)was added to 1%, and the virus was stored at –80 °C.
For infections in the presence of the farnesyl transferase inhibitor
(Zarnestra), MEK inhibitor (UO126, Millipore; Bilerica, USA) and PI3K
inhibitor (LY294002, Invitrogen; Camarillo, USA), cells were serum-
starved for 24 h and pre-treated with drugs for 1 h prior to infection.
Cells were then stimulated by dropwise addition of FBS and infected
by dropwise addition of the virus. All drugs were solubilised in DMSO
and all dilutions were made such that each dish of cells received an
equal volume of DMSO. Cells were maintained in each drug for the
duration of the experiment.
2.3. Release of infectious virions
The shedding of HCMV infectious virions from drug-treated or
untreated 208 F, FE-8 and IR4 cells was investigated by a standard
plaque-forming assay. Supernatant samples were collected from cell
cultures and stored at −80 °C. Subsequently, an end-point dilution
method was employed as follows: logarithmic dilutions were used to
inoculate monolayers of HFF in three parallel series. After absorption
for 2 h, the inoculum was replaced with normal culture medium
containing anti-HCMV serum. Infections were allowed to progress
until viral plaques were observed. The results from supernatant
samples were expressed as PFU per milliliter. The assays were
performed three times and the averages of the results±one standard
deviation are presented.
2.4. Viral nucleic acid isolation and analysis
For real-time PCR, DNA was extracted from virus-infected cells at
8, 24, 96 and 144 hours post-infection (h.p.i.), using the DNeasy tissue
kit (QIAGEN, Hilden, Germany). Quantiﬁcation of viral input DNA by
real-time PCR was performed using the Q-CMV Real Time Complete
Kit (Nanogen Advanced Diagnostics, Italy). For each sample, DNA
extracts were analyzed in triplicate.
2.5. Retroviral infection
2×106 HEK293T cells were transfected using TurboFect (Fermentas,
USA) with 8 μg of retroviral vector pBabe-H-RasV12 (courtesy of
Stephane Ansieau, Lyon, France) [46]. pBabe-purowas used as a control
retroviral vector. Forty-eight hours after the transfection, the superna-
tant was harvested, ﬁltered and aliquots were stored at −80 °C. The
supernatant was applied to 106 U373MG human glioblastoma–
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Polybrene (Sigma-Aldrich, USA). Infected cells were selected after 48 h
using Puromycin (0.5 μg/ml) (Sigma-Aldrich, USA).
2.6. Plasmids and transfection assays
The pEGFP-C2 plasmid was purchased from Clontech Laboratories
Inc., USA. The plasmid pEGFP-IE1 was generated after fusion of the ie1
gene derived from the pGEX-3X-IE1 [40] to the Clontech vector
pEGFP-C2. The expression vector pEGFP-IE2 [41] has been described
previously. For transfection experiments, 208F or FE-8 cells were
seeded either on glass coverslips or into four-well, chambered
coverglass units with coverslip quality glass bottoms (Lab-Tek;
Nunc). For transient expression assays, DNA (1 μg/well) was intro-
duced in subconﬂuent cells using the TransPEI transfection reagent
(Eurogentec, Belgium) according to the manufacturer's instructions.
2.7. Proliferation assay
To measure the effects on cell proliferation over time due to HCMV
infection, total cell count assays were performed [42]. Brieﬂy, 2×106
208F and FE-8 cells were plated in 6-well plates in the absence of FBS
and were subsequently infected with wt-HCMV, UV-irradiated HCMV
or mock infected at MO1=1. The cells from duplicate plates were
trypsinized 3 days post-infection, resuspended in DMEM and counted
using a hemacytometer. Cells were stained using Trypan Blue (Sigma-
Aldrich, USA) dye at 0.8 mM, which was mixed at equal (1:1) parts
with suspended cells. All proliferation experiments were performed
at least three times. Additionally, 2×106 U373MG cells were plated
in 6-well plates and subsequently infected with wild-type HCMV, UV-
irradiated HCMV or mock infected. The cells from duplicate plates
were trypsinized 3 days post-infection, resuspended in DMEM and
counted using a hemacytometer. Furthermore, U373MG cells trans-
duced with either the pBabe or pBabe-H-RasV12 retroviruses were
plated in 6-well plates and infected with HCMV (MOI=3) to quantify
their proliferation at 1, 3 and 5 days after the infection. Cells were
resuspended in DMEM and counted using a hemacytometer. Cell
counting was carried out by Trypan Blue (Sigma-Aldrich, USA) dye
staining as described above.
2.8. Focus formation transformation assays
To determine whether HCMV could modulate the focus forming
activity of the activated H-ras (12 V), FE-8 cells were infected with
HCMV at MOI=1 in 6-well plates. The cells were then maintained in
DMEM supplemented with 1% calf serum. The appearance of
transformed foci of cells was quantitated 3–5 days post-infection
[43]. Similarly, the human U373MG cells were transduced with
retroviruses expressing either the pBabe-H-RasV12 or the empty
pBabe vector and subsequently were infected with HCMV at MOI=3.
Images were taken 3 weeks after the infection to visualize foci
formation. In some experiments, the Ras inhibitor (FTI R115777), the
MEK1/2 inhibitor (PD098059), the PI3K inhibitor (LY294002) and the
HCMV inhibitor (PAA) were added to the medium at a concentration
of 200nM, 50 μM, 200 μg/ml and 1 μM, respectively. All assays were
performed in triplicate.
2.9. In vitro wound healing assay
FE-8 cells were seeded in 24-well culture plates at a concentration
of 80,000 cells per well. The cells were cultured in an incubator at
37 °C and 5% CO2 and 24 h after plating, theywere either infectedwith
HCMV (M.O.I.=1) or mock infected. The cell layer was wounded by
scratching with a sterile 10 μL pipette tip after 48 h of infection.
Detached cells were removed by washing two times with serum-free
medium. The wound closure was monitored at 0, 3, 6 and 9 h.p.i.,using a digital image processor connected to an inverted microscope.
Cell motility was quantiﬁed by image analysis (ImageJ 1.4.3.67
Launcher Symmetry Software). Each experiment was carried out in
triplicates and the error bars represent the mean standard error.
2.10. Indirect immunoﬂuorescence analysis
For indirect immunoﬂuorescence analysis, 2×105 208F and FE-8 cells
were plated on glass coverslips placed in 24-well plates. Themediumwas
aspirated, the cells were washed with phosphate-buffered saline (PBS)
andHCMVwas added atMOI=1 and themixturewas incubated at 37 °C
for 2 h. The inoculum was subsequently removed, fresh medium was
added and the cells were incubated for 72 h. The cells were then ﬁxed,
permeabilized and indirectly stained for the viral pp65 protein, using the
CMVpp65AntigenemiaAntibody kit by LightDiagnostics (Temecula, CA).
2.11. Apoptosis assays
Apoptosis was evaluated by applying both caspase-3 staining and a
DNA fragmentation assay. 2×105 FE-8 cells were plated on glass
coverslips placed on 24-well plates, infected at MOI=1 with HCMV
and then incubated for 2 and 3 days post-infection. At the above time
points the cells were ﬁxed and stained with a caspase-3 rabbit
polyclonal antibody (Santa-Cruz Biotechnology Inc., sc-7148) at a
dilution of 1:200, as well as with an IE1 mouse monoclonal antibody
(BS500) at a dilution of 1:50. After primary incubation, cells under-
went secondary staining for 1 h with secondary conjugated anti-
bodies, rabbit Cy3 (Invitrogen) and the mouse Alexa-488 (Invitrogen)
at a dilution of 1:500, respectively. The coverslips were then inspected
under an epiﬂuorescence microscope.
ForDNA fragmentation analysis,mock andHCMV-infected FE-8 cells
were harvested 1, 2 and 3 days post infect and resuspended in a solution
containing 10 mM Tris, pH 8, 10 mM EDTA, and 150 mM NaCl. Cells
were then incubated with 0.1 mg/ml proteinase K and 1% SDS at 50 °C
overnight. The samples were extracted in phenol-chloroformisoamyl
alcohol and ethanol precipitated, and the pelletswere washedwith 70%
ethanol and dried. The pellets were resuspended in Tris–EDTA (TE), pH
7.5. The DNA was electrophoresed in a 3% agarose gel and ethidium
bromide stained [39].
2.12. Western blotting
For Western blotting, cell lysates from HCMV-infected and mock-
infected cells were harvested using the M-PER Mammalian Protein
Extraction Reagent (Thermo Scientiﬁc, Rockford, IL, USA), enriched
with the Halt-Protease Inhibitor Cocktail, EDTA-free (PIERCE, Rock-
ford, IL, USA) according to the manufacturer's instructions. Proteins
were separated on 12% polyacrylamide gels containing Sodium-
Dodecyl Sulphate, and then transferred to nitrocellulose membranes.
The Western blotting and chemiluminescence detection were
performed as previously described [44]. The HCMV IE1 and UL44
gene products were detected using mouse monoclonal antibodies
against IE1-72KDa (BS500) and ppUL44 (BS510) as previously
described [45]. Mouse monoclonal anti-actin antibody was used at a
dilution of 1:4000 (Pierce, Rockford, IL, USA); while secondary anti-
rabbit (AP132P) and mouse (AP124P) conjugated Horseradish
Peroxidase antibodies were purchased from CHEMICON (Temecula,
CA, USA) and used at a dilution of 1:5000.
3. Results
3.1. Increased viral expression and progeny virus in H-ras-transformed
cells
In view of the signiﬁcance of several oncogenes in the outcome of
herpesvirus infection, we ﬁrst investigated the role of the oncogenic
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8 cells transformed with H-ras (12 V) as well as IR-4 cells which
inducibly express activated H-ras were infected with HCMV, at
MOI=0.1 and MOI=1. More speciﬁcally, the growth properties of
progeny virus were assessed by single-step growth curve analyses by
collecting supernatants from infected 208 F and FE-8 cells at time
points corresponding to 1, 3, 5 and 7 days post-infection. The viral
yield from the abovementioned time points was signiﬁcantly
increased in the FE-8 cells when compared to the parental 208F
cells, at both MOI=0.1 and MOI=1, peaking at seven days post-
infection (Fig. 1A, a and b). Consistently, supernatants collected from
infected IR-4 cells, produced an increased viral yield when the cells
were treated with IPTG, which induces H-ras (12 V) expression, as
opposed to when they were not treated with IPTG. We observed that
the viral yield in the IPTG-induced IR-4 cells was increased both at low
and high MOI, showing a peak at seven days post-infection, similar toFig. 1. Increased HCMV expression and progeny virus in H-ras-transformed cells. A: Single
infected with HCMV AD169 at MOI=0.1 and MOI=1. Supernatants were collected at 1, 3,
plaque-forming units per ml of virus (pfu/ml). Error bars represent the standard deviation
infected with wild-type HCMV strain AD169 at MOI=1 and MOI=0.1. IR-4 cells were eit
Supernatants were harvested at different time points post-infection as indicated, followed b
HCMV AD169 at MOI=1 and DNA was extracted at 8, 24, 96 and 144 h following infection
copies. C: Comparison of HCMV protein expression between infected 208 F and FE-8 cells. Cel
by 12% SDS-PAGE gel electrophoresis. Immediate Early HCMV protein IE1 and the Early UL44
equal protein loading.the results we observed in the 208F and FE-8 infected cells (Fig. 1A, c
and d).
Additionally, we sought to determine the viral particle-to-PFU
ratios between 208 F and FE-8 at different time points of the infection.
For this purpose, DNA was extracted from 208F and FE-8 cells at 8, 24,
96 and 144 hours post-infection and quantiﬁed by real-time PCR
(Fig. 1B). The viral particle uptake was equivalent between the 208F
and FE-8 cells, as indicated by the amount of viral DNA detected 8 h.p.i.
Interestingly, the number of viral DNA copies signiﬁcantly increased
during the course of the infection in the H-ras-transformed cells when
compared to the 208F cells in a manner similar to the produced
progeny virus we observed earlier. These data suggest that an
activated Ras signaling pathway confers a functional advantage for
the DNA replication of HCMV.
The permissiveness to HCMV was also assessed at the level of viral
protein synthesis. The expression levels of indicative HCMV proteins-step growth analysis of infected 208 F and FE-8 cells. a, b, 208 F and FE-8 cells were
5 and 7 days following infection and the viral titers were evaluated and represented as
derived from three independent experiments. c and d, Inducible Ras (IR-4) cells were
her stimulated with IPTG to induce H-ras (V12) expression, or not treated with IPTG.
y quantiﬁcation of the observed viral plaques. B: 208F and FE-8 cells were infected with
. Quantitative real-time PCR results were used to evaluate the input of HCMV genome
ls were harvested at the indicated time points after infection and the proteins separated
protein were analyzed by Western blotting. Cellular actin levels served as a control for
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were examined by Western blot analysis (Fig. 1C). The infection of FE-
8 cells by HCMV resulted in an increasing expression pattern for both
viral proteins peaking on the seventh day post-infection. On the
contrary, the viral protein expression in the infected parental 208F cells,
for both IE1 and UL44, remained at basal levels throughout the time
course of the infection, raising more questions on the role of HCMV
infection in the H-ras-transformed cells. Additional experiments using
HCMV-permissive [36] human glioma cells U373MG indicated that
HCMV infection is enhanced in cells that express the mutated form of
Ras. The expression levels of IE1 and UL44 were observed by Western
blot of U373MG cell lysates at 1, 3 and 5 days post-infection. Cells
retrovirally expressing the mutated H-RasV12 showed an increased
expression of viral proteins at 3 and 5 d.p.i. when compared to cells that
did not express the mutant Ras protein (Supplementary Fig. S1).
Taken together, these results demonstrate that the Ras signaling
pathway plays an important role in HCMV infection.
3.2. Inhibition of HCMV infection by Ras inhibitors
The role of ras genes during normal cellular function is dictated by
the post-translational modiﬁcations to which the proteins are
subjected. Farnesylation, the main Ras modiﬁcation, precedes the
plasma membrane anchorage of Ras proteins which in turn de-
termines their status, active or inactive [47]. If Ras, is in fact involved
in HCMV infection, then inhibition of the farnesylation should block
HCMV replication in the transformed cells. Treatment of HCMV-
infected ras-transformed cells with the farnesyl transferase inhibitorFig. 2. Inhibition of HCMV infection by Ras inhibitors. A: Titration of HCMV virion
shedding by plaque assay quantiﬁcation. FE-8 cells were infected with HCMV (MOI=1)
or treated with PAA, FTI, MEK inhibitor and PI3K inhibitor prior to infection.
Supernatants from drug-treated FE-8 cells were subjected to plaque-forming assay as
described in the Materials and methods section. Viral plaque formation was assessed
and expressed as pfu/ml of virus stock. Infection and plaque assay experiments were
performed in triplicate. B: Western blotting analysis using antibodies against viral IE1
and UL44 proteins. FE-8 cells were pre-treated with four inhibitors (PAA, FTI, MEK,
PI3K) and subsequently were infected with HCMV (MOI=1) and harvested at 3 days
post-infection. Actin served as a control for equal protein loading.FTI, resulted in a markedly reduced progeny virus compared to the
non-treated cells (Fig. 2A). The low viral yield of the FTI-treated cells
was comparable to the blockage caused by the known HCMV inhibitor
phosphonoacetic acid (PAA). These results are consistent with the
idea that HCMV infection requires an activated Ras signaling pathway.
GTP-bound RAS is able to bind and activate effector enzymes of
important pathways downstream of Ras and among others, the Ras-
Raf-MEK-ERK-MAP kinase cascade and the PI3K pathway [48]. To
determine whether MEK1/2 or PI3K activities are required for HCMV
infection, we studied the effect of the PD098059 and LY294002
inhibitors, respectively, on the infected ras-transformed cells. HCMV
titration assays showed that both inhibitors also blocked viral
replication in the ras-transformed cells. However, the effect was not
that striking compared to FTI. The effects of the above inhibitors on
the progeny virus were also mirrored by their effects on the viral
protein synthesis as compared to the non-treated ras-transformed
cells (Fig. 2B). The concentrations of all drugs used did not inhibit the
overall protein synthesis (data not shown). Collectively, our results
strongly suggest the implication of an active Ras signaling pathway for
a productive HCMV infection, while the downstream ERK and PI3K
pathways are partially involved in HCMV infection.
3.3. Effect of HCMV infection in H-ras-transformed and non-transformed
cells
HCMV modulates important properties of the host, such as cell
cycle regulation or apoptosis [7]. Considering the above regulatory
effects of HCMV on the host, we sought to investigate potential
changes of the proliferation rate and motility properties of ras-
transformed and non-transformed infected cells. For this purpose,
208F and FE-8 cells were infected with HCMV at MOI=1, mock
infected, or infected with UV-irradiated HCMV. The proliferation
characteristics of the infected cells were signiﬁcantly different,
depending on the ras status. The HCMV-infected parental 208F cells
exhibited only a slight increase in the number of cells compared to the
mock-infected cells (Fig. 3A). Strikingly, the HCMV-infected FE-8 cells
exhibited a signiﬁcant increase in the proliferation rate 3 days post-
infection, in comparison to the non-infected cells (pb0.05). Infection
of both ras-transformed and non-transformed cells with the UV-
inactivated HCMV had nomajor effect on the growth properties of the
cells, providing evidence that the adhesion of the virus alone is not
sufﬁcient, but active viral gene expression is required for the
increased proliferation of the H-ras transformed cells. Similar
experiments in U373MG cells that were either transduced with
pBabe-H-RasV12 or with the empty pBabe vector, were carried out by
infecting them with HCMV, UV-inactivated HCMV or mock infected.
Interestingly, the proliferation of the pBabe-H-RasV12 transduced
U373MG cells that were infected by HCMVwas increased signiﬁcantly
at 3 d.p.i when compared to the empty vector-transduced cells or the
UV-HCMV-infected cells (Supplementary Fig. S2A). Furthermore, the
retroviral expression of H-RasV12 combined with HCMV infection
conferred to the cells a proliferative advantage over time (Supple-
mentary Fig. S2B).
In addition, an in vitro “wound healing” assay demonstrated lower
migration efﬁciency of the HCMV-infected compared to the mock-
infected ras-transformed cells. Our results showed that HCMV-
infected FE-8 cells closed 32.2%±1.9% of the inﬂicted wound area
9 h post-infection, as compared to the 16.4%±1%closure of the mock-
infected cells at the same time point (Fig. 3B and C). These data clearly
shows that HCMV enhances the migration capacity of the ras-
transformed cells, augmenting their oncogenic potential.
3.4. Formation of cellular foci upon infection of H-ras-transformed cells
Oncogenic forms of RAS are locked in their active state and transduce
signals essential for several oncogenenic processes including cellular
Fig. 3. Effect of HCMV infection in H-ras-transformed and non-transformed cells. A: Comparison of proliferation rate between HCMV-infected 208F and FE-8 cells. The cells were
initially serum-starved and subsequently were either mock-infected, infected with wild-type HCMV or UV-irradiated HCMV atMO1=1. Cell counting was performed on viable cells,
stained with Trypan Blue, using a hemacytometer. B: FE-8 cells were plated in 6-well plates and infected with HCMV or mock infected. The monolayer was “wounded” 48 hpost-
infectionwith a 10 μl sterile pipette tip and the detached cells were removed. Images were taken at 0, 3, 6 and 9 h after the scratch tomonitor cell motility. C: Quantiﬁcation of wound
healing was performed using the ImageJ image analysis software. The results were expressed as % of closure of wound surface area at different time points (at time point 0 h the
wound surface area was the 100%).
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involving the RAF/MEK/ERK cascade of cytoplasmic kinases, the
phosphatidylinositol3-kinaseandothers [49,50]. In the208F/FE-8system,
the preneoplastic 208F cells donot transformspontaneously,whereas the
malignant FE-8 cells are anchorage-independent [51]. To further
investigate the impact of HCMV on the transformation properties of
V12 H-ras-activated cells, 208F and FE-8 cells were either infected by
HCMV or mock infected and the cells were observed at 5 days post-
infection. In our experiments, inefﬁcient foci formation was observed in
both HCMV and mock-infected parental 208 F cells (Fig. 4A, a and b). On
the contrary, HCMV-infected FE-8 cells exhibited a remarkable prolifer-
ation potential, forming cellular foci that were signiﬁcantly larger in size(over 200 μm)andnumber (160±6 foci) compared to themock-infected
cells (45±3 foci) (pb0.05) (Fig. 4A, c and d). Moreover, human glioma
cells U373MGwere transducedwith either the pBabe-H-RasV12 retroviral
vector or the empty vector, followed by HCMV infection and allowed to
incubate for several weeks. The cells were regularly monitored for foci
formation and to observe differences between the retroviral H-RasV12
expressing cells as well as the HCMV-infected and mock-infected cells
(SupplementaryFig. S3). TheU373MGcells, in the absenceof retroviralH-
RasV12 expression did not exhibit any cellular focus after 3 weeks of
incubation, regardless the HCMV infection (Supplementary Fig. S3 a and
b). Consistentlywith the aforementioned experiment in FE-8 cells, HCMV
infection resulted in the development of higher number of cellular foci in
Fig. 4. Formation of cellular foci upon infection of H-ras-transformed cells. A: 208 F (a, b)
and FE-8 (c, d) cells were plated in 6-well plates and eithermock infected or infectedwith
HCMV at MOI=1. Cellular foci were observed at 3–5 days following infection (bars,
10 μm). B: FE-8 cells were treated with PAA, FTI, MEK inhibitor or PI3K inhibitor, 1 h prior
to infection with HCMV. The cellular foci of FE-8 cells were quantitated at 5 days after
infection. Foci formation assays were performed in triplicate. Error bars indicate
deviations between experiments.
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S3 c and d). These results support the previously reported oncomodu-
latory role of HCMV which is incapable of transforming cells on its own.
However, it signiﬁcantly augments the transformation efﬁciency of
constitutively activated H-Ras (12 V) cells.
To further explore the role of Ras/MEK/ERK and Ras/PI3K/Akt
pathways in the formation of the above cellular foci, we performed
inhibitor assays on HCMV-infected FE-8 cells and evaluated the
number of cellular foci forming at 5 days post-infection (Fig. 4B).
Inhibition of the viral infection by the HCMV replication inhibitor
phosphonoacetic acid (PAA) reversed the cellular foci formation
bringing it closer to the mock-infected numbers. The involvement of
Ras in the cellular foci formation upon HCMV infection was
investigated by the addition of the farnesyl transferase inhibitor
(FTI), which not only reversed the foci formation but accomplished a
slight reduction in foci numbers compared to the mock-infected cells.
Finally, the addition of MEK (PD098059) and PI3K (LY294002)
inhibitors resulted in a partial reversion of the cellular foci formation,
indicating the probable involvement of these Ras effectormolecules in
the transformation properties of FE-8. Similar results were obtained
when the above experiment was repeated in the human glioblastoma
U373MG cell line after retroviral transduction (data not shown).3.5. Preferential localization of HCMV virions onto ras-transformed
cellular foci is not due to IE1 and IE2
In order to further verify the additive effect of HCMV on the focus
formation properties of the H-ras-transformed cells, the localization
of the newly synthesized viral particles was investigated in both the
208F and FE-8 cells. The viral structural protein, pp65, was used as a
marker for the detection of the progeny virions. Immunoﬂuorescence
staining for the aforementioned viral protein demonstrated that pp65
was relatively evenly distributed among the infected 208F cells,
indicating an overall infection of these cells (Fig. 5A, b). Interestingly,
the viral protein was found to be almost exclusively localized on the
cellular foci (Fig. 5A, d). Although the H-ras transformed cells did not
form a typical ﬂat monolayer in the cell culture however, analysis of
highermagniﬁcation images conﬁrmed the preferential localization of
pp65 onto the cellular foci (Fig. 5A, f). The striking association of the
viral protein onto the foci of FE-8 cells further supports our hypothesis
that HCMV infection induces the formation of the cellular foci and
enhances the transformation capabilities of the H-ras-transformed
cells.
In efforts to delineate a potential function of HCMV in the
neoplastic process of H-ras-transformed cells, we investigated
biological properties emanating from its immediate early gene
products IE1 and IE1, which are key regulators of virus replication
and survival [52,53]. For this purpose, FE-8 cells were transiently
transfected with plasmids expressing either the IE1 protein (pEGFP-
IE1) or the IE2 protein (pEGFP-IE2). The empty vector plasmid pEGFP-
C1 was used as the control, to verify possible foci formation. The
overexpression of either IE1 or IE2 gene products did not result in any
distinct morphological alteration in the FE-8 cells (Fig. 5B). Neither
IE1 nor IE2 induced focus formation within 5 days post transfection,
indicating the absence of primary transforming activity. Moreover,
selected mass populations did not exhibit colony formation in semi-
solid medium, showing lack of anchorage-independent growth. Given
the high sensitivity of FE-8 cells in detecting transforming properties,
the above ﬁndings directing oncogenic activity were not associated
with either IE1 or IE2 proteins.3.6. Enhanced apoptosis in HCMV-infected H-ras-transformed cells
HCMV infection is known to block the apoptotic process of the
host-cell, by affecting death receptor signaling pathways, such as the
TNF-mediated death receptor signaling pathway [54,55]. Therefore,
we investigated the effects of HCMV infection on the H-ras-
transformed cells and whether the ras oncogene plays a role in the
process of apoptosis. Caspases are a protein family of proteases that
play a crucial role in the programmed cell death [56,57]. Caspase-3 in
particular is a good indicator for investigating cellular apoptosis.
Consequently, FE-8 cells were either mock infected or infected with
HCMV and ﬂuorescently labeled for the viral protein IE1 and caspase-
3. The mock-infected FE-8 cells did not exhibit any caspase-3
expression at 2 days, whereas there was minimal caspase-3 activation
at 3 days of culture. Interestingly, the HCMV-infected FE-8 cells
showed signiﬁcant caspase activation even at 2 days post-infection, a
phenomenon that peaked at 3 days post-infection (Fig. 6A).
Moreover, whole cell extracts of HCMV and mock-infected FE-
8 cells were harvested at 1, 2 and 3 days, followed by DNA extraction.
The DNA extracts were then loaded on an agarose gel and visualized
by ethidium bromide staining, for DNA fragmentation patterns. DNA
fragmentation is one of the ﬁnal steps of apoptotic cell death, where
DNA cleavage produces DNA fragments of various sizes. In our
experiment themock-infected FE-8 cells exhibited basal levels of DNA
laddering, whereas the effect wasmore distinct on the HCMV-infected
cells, indicating an increase in DNA degradation at 2 and even more at
3 days post-infection (Fig. 6 B).
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Human cytomegalovirus initiates infection and intracellular
signaling by binding to its cellular cognate receptors and by activatingseveral signaling pathways, including those mediated by PI3K [21],
mitogen-activated protein kinases [20,22,58] and G proteins [59]. In
the present study, we examined the involvement of host-cell Ras
signaling pathway in human cytomegalovirus infection. Our experi-
ments indicated a direct implication of the Ras protein in the progress
of HCMV infection. Both the progeny virus and viral expression levels
were signiﬁcantly enhanced in the H-ras-transformed cells, whereas
non-transformed cells (208F) or cells with inactivated oncogenic Ras
(IR4) restrained viral infection to basal levels. Inhibition of the Ras
protein by the farnesylation inhibitor (FTI) resulted in decreased viral
progeny verifying a functional link between HCMV infection and Ras
protein expression. Molecules downstream of Ras, such as ERK or PI3K
were also involved but in a lower extent suggesting that the activated
Ras protein poses a major role for a productive HCMV infection.
Herpes Simplex Virus type-1 (HSV-1) but also its mutant versions or
the oncolytic herpes G207 have been shown to exploit the activated
Ras signaling pathway to increase viral permissiveness by inhibiting
the virus-induced activation of the stranded RNA-activated protein
kinase (PKR) [60–62]. Additionally, reovirus also takes the advantage
of the activated Ras signaling in the host cell, resulting in increased
viral permissiveness by suppressing the IFN-β production through
negative regulation of RIG-I signaling [63–65] while the RAS/Raf1/
MEK/ERK signaling pathway also facilitates VSV-mediated oncolysis
[66,67]. Apparently, HCMV has also evolved mechanisms to usurp an
already activated signal transduction pathway, the Ras signaling
pathway, rendering the cells more susceptible to viral infection.
Emerging evidence suggests that HCMV infection and expression
may be speciﬁcally associated with human cancers by deregulating
signaling pathways involved in the initiation and promotion of
malignancy [8,68,69]. One signiﬁcant ﬁnding of this study was the
increased proliferation rate of the HCMV-infected Η-ras-transformed
ﬁbroblasts, when compared to their parental non-transformed cells,
which is justiﬁed by the activation of the Ras protein [70]. Strikingly,
the proliferation rate of both cell lines was increased when they were
infected by HCMV, while the transformed cells exhibited the highest
levels of proliferation and cell motility. H-ras transformed ﬁbroblasts
seem to provide an ideal environment for HCMV replication,
exploiting the host-cell Ras/Raf/MEK/ERK pathway to regulate and
increase the proliferation rate of the infected cells. The Immediate
Early protein IE1 plays a crucial role in viral DNA replication and acts
as a precursor protein for the expression of subsequent viral proteins
[71,72]. In addition, the Early UL44 protein is essential to HCMV DNA
replication because it acts as an accessory protein to the viral DNA
polymerase [73,74]. The expression levels of both proteins were
notably elevated in the ras-transformed ﬁbroblasts establishing a
direct association between the host-cell Ras protein and HCMV.
However, the function of these particular viral proteins does not
appear to directly affect the proliferative status of neither the
transformed nor the non-transformed cells.
H-ras (G12V) transformed cells (FE-8) tend to accumulate in
clusters of cells, forming cellular foci [51,75]. This characteristic which
is expected in transformed cells was profoundly enhanced by HCMV
infection. Remarkably, HCMV proteins were almost exclusively
localized in these cellular foci, increasing the transformation potential
of FE-8 cells, whereas the presence of a HCMV inhibitor (PAA), or the
MEK and PI3K inhibitors reversed the cellular foci formation close to
that of uninfected cells. It is possible that HCMV infection provides
selective pressure for tumor cell populations with increasedFig. 5. Preferential localization of HCMV virions onto ras-transformed cellular foci but is
due to IE1 and IE2. A: 208 F (a, b) and FE-8 (c–f) cells were plated on glass coverslips
and were either mock infected or infected with HCMV at MOI=1. The viral tegument
protein pp65 was stained by indirect immunoﬂuorescence as described in theMaterials
and methods section. B: FE-8 cells were seeded into four-well, chambered units with
coverglass quality glass bottoms. 1 μg/ml plasmid DNA was transfected to the cells for
transient expression of IE1 (c, d), IE2 (e, f) or pEGFP-C1 (a, b). The EGFP signal was
observed on an epiﬂuorescence microscope 72 h following transfection.
Fig. 6. Enhanced apoptosis in HCMV-infected H-ras-transformed cells. A: FE-8 cells were plated on glass coverslips, mock-infected or infected with HCMV at MOI=1 and then
incubated for 2 and 3 days post-infection. Cells were stained for IE1 (red color) and for activated caspase-3 (green color). B: Both infected and uninfected FE-8 cells were harvested at
1, 2 and 3 days post-infection. Genomic DNA was isolated and subsequently electrophoresed on a 3% agarose gel. Small DNA fragments mainly between 250 and 750 bp yielded a
“ladder” pattern on the agarose gel (see brackets). M: 1Kb DNA ladder.
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been associated with increased transformation of these cells [16,27].
Although HCMV does not directly transform cells in vitro, data
acquired from viral infection of transformed cells indicate that the
overall geneticmicroenvironment of themalignant cell enables HCMV
to further upset the balance [18]. Therefore, it could be suggested that
the activated Ras signaling pathway facilitates the establishment of a
favorable tumor microenvironment where HCMV is capable to
modulate normal cellular functions such as cell proliferation or
motility and ﬁnally promote a malignant phenotype.
A key property of nearly all tumor cells is the resistance to
apoptosis and the attenuation of cell proliferation and differentiation.The HCMV Immediate Early protein IE2 is known to suppress
apoptotic cell death in the host-cell, at least until successful viral
replication takes place. During HCMV infection, the expression of IE2
is responsible for the inhibition of p53, TNF-α and Doxorubicin-
induced apoptosis [76–78]. HCMV protects malignant cells from
apoptosis, by activating the cellular proteins AKT, Bcl-2 and ΔΝp53α
[79]. As regards the Ras protein and apoptosis, the activation of Ras
modulates the expression of several genes involved in apoptosis [80].
The oncogenic Ras can either promote or inhibit apoptosis, depending
on the cell type and the nature of the apoptotic stimuli. It is known
that the oncogenic ras (12 V), is able to induce apoptosis in colon
cancer cells, by increasing the sensitivity of the cells to 5-FU-induced
1881H. Filippakis et al. / Biochimica et Biophysica Acta 1813 (2011) 1872–1882apoptosis [81] or in response to sulindac [82] or other chemothera-
peutic agents [83]. Additionally, there are several proapoptotic genes
that are downregulated in human tumors and could explain the
increased apoptosis in ﬁbroblasts carrying the oncogenic ras[84].
Interestingly, the investigation of the effect of HCMV infection in
apoptosis using this particular oncogenic Ras model, revealed an
increased susceptibility to apoptosis of the H-ras-transformed cells
compared to their parental cells. Apparently, the previously proa-
poptotic properties of the oncogenic Ras (12 V) dominate over the
antiapoptotic action of HCMV, tilting the balance towards apoptotic
cell death. Coupled with the higher viral titers detected in the H-ras-
transformed cells, we make the key connection between apoptosis,
which leads to enhanced virus release and efﬁcient spread of infection
in ras-transformed cells. Alternatively, the infected H-ras transformed
cells could advance to apoptosis in order to inhibit the unusually high
proliferation rate induced by HCMV.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.07.003.
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